Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedSep 18, 2013MIC-CARN + B6/B12/LIDOCAINE 25/50/50/175MCG/1/0.1MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-980-2013Class IITerminatedSep 18, 2013METHYLPREDNISOLONE ACETATE 40 MG/ML and 80 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-979-2013Class IITerminatedSep 18, 2013METHYLCOBALAMIN 1 mg/mlLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-978-2013Class IITerminatedSep 18, 2013MAGNESIUM SULFATE 50% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-977-2013Class IITerminatedSep 18, 2013MAGNESIUM CHLORIDE HEXAHYDRATE 20% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-976-2013Class IITerminatedSep 18, 2013LIPOIC ACID 100 MG/ML and 200 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-975-2013Class IITerminatedSep 18, 2013LIPO-PLEX INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-974-2013Class IITerminatedSep 18, 2013LIDOCAINE MDV 1% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-973-2013Class IITerminatedSep 18, 2013L-TRYPTOPHAN 300 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-972-2013Class IITerminatedSep 18, 2013KETOROLAC TROMETHAMINE 60 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-971-2013Class IITerminatedSep 18, 2013HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-970-2013Class IITerminatedSep 18, 2013HYDROXOCOBALAMINLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-969-2013Class IITerminatedSep 18, 2013HYALURONIDASE 150 U/ML and 200 U/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-968-2013Class IITerminatedSep 18, 2013HYDROGEN PEROXIDE 3% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-967-2013Class IITerminatedSep 18, 2013H.C.G. (COMPOUNDED)Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-966-2013Class IITerminatedSep 18, 2013GLYCYRRHIZIC ACID 8 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-965-2013Class IITerminatedSep 18, 2013GLYCINE 50 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-964-2013Class IITerminatedSep 18, 2013GLUTATHIONE/METHYL/LIDO 100/25/20 MG/ML INJ SOLN and GLUTATHIONE/METHYL/LIDO 100/25/20MG/MLLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-963-2013Class IITerminatedSep 18, 2013GLUTATHIONE/LIDO 100MG/2%/MLLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-962-2013Class IITerminatedSep 18, 2013GLUTATHIONE 200 MG/MLLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-961-2013Class IITerminatedSep 18, 2013GLUTAMINE 100 MG/ML INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-960-2013Class IITerminatedSep 18, 2013FUROSEMIDE 10 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-959-2013Class IITerminatedSep 18, 2013FREAMINE III ALT. 8.5% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-958-2013Class IITerminatedSep 18, 2013ESTRIOL 5 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-957-2013Class IITerminatedSep 18, 2013ESTRADIOL VALERATE W/ LIDOCAINE 1% 40 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-956-2013Class IITerminatedSep 18, 2013ESTRADIOL CYPIONATE 5Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-955-2013Class IITerminatedSep 18, 2013ESTRADIOL CYP/PROG/TEST CYP 0.5/10/10 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-954-2013Class IITerminatedSep 18, 2013EDETATE DISODIUM 150 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-953-2013Class IITerminatedSep 18, 2013DUAL-TESTOSTERONE 20Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-952-2013Class IITerminatedSep 18, 2013DMPS 50mg/ml INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-951-2013Class IITerminatedSep 18, 2013DMSO 50% INJ 50 ML VIAL INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-950-2013Class IITerminatedSep 18, 2013DEXTROSE PF 50% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-949-2013Class IITerminatedSep 18, 2013DEXPANTHENOL 250 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-948-2013Class IITerminatedSep 18, 2013DEXAMETHASONE SODIUM PHOSPHATE 10 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-947-2013Class IITerminatedSep 18, 2013CYANOCOBALAMIN 1000 MCG/ML INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-946-2013Class IITerminatedSep 18, 2013COPPER 0.4MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-945-2013Class IITerminatedSep 18, 2013CHROMIUM 4 MCG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-944-2013Class IITerminatedSep 18, 2013CALCIUM CHLORIDE 100 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-943-2013Class IITerminatedSep 18, 2013BI-TROPIN S-2 INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-942-2013Class IITerminatedSep 18, 2013BI-MIX PHENTOLAMINE/PAPAVERINE 0.5 MG/30 MG/ML and BI-MIX PHENTOLAMINE/PAPAVERINE 1 MG/30 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-941-2013